Lysozyme is a major secretory product of human and rodent macrophages and a useful marker for myelomonocytic cells. Based on the known human lysozyme amino acid sequence, oligonucleotides were synthesized and used as probes to screen a phorbol 12-myristate 13-acetatetreated U937 cDNA library. A full-length human lysozyme cDNA clone, pHL-2, was obtained and characterized. Sequence analysis shows that human lysozyme, like chicken lysozyme, has an 18-amino-acid-long signal peptide, but unlike the chicken lysozyme cDNA, the human lysozyme cDNA has a >1-kilobase-long 3' nontranslated sequence. Interestingly, within this 3' region, an inverted repeat of the Alu family of repetitive sequences was discovered. In RNA blot analyses, DNA probes prepared from pHL-2 can be used to detect lysozyme mRNA not only from human but also from mouse and rat. Moreover, by in situ hybridization, complementary RNA transcripts have been used as probes to detect lysozyme mRNA in mouse macrophages and Paneth cells. This human lysozyme cDNA clone is therefore likely to be a useful molecular probe for studying macrophage distribution and gene expression. Lysozyme (EC 3.2.1.17) is a muramidase, which hydrolyzes
1,4-p linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine in the bacterial cell wall. Lysozyme has been extensively used as a model system for a large number of important studies (1) , notably x-ray crystallography for protein structure determination (2) and mechanism of enzyme action (3) . It is well known that lysozyme is synthesized by certain glandular epithelial cells and some leukocytes. By screening a large number of human and mouse cell lines with characteristics of T lymphocytes, B lymphocytes, lymphomas, and myeloma, only cells from the myelomonocytic lineage were shown to synthesize lysozyme (4) . Since granulocytes and macrophages are probably a major source of lysozyme found within tissues, lysozyme can act as a very useful specific marker for the myelomonocytic lineage in normal and disease states. Indeed, increased levels of lysozyme in urine and serum are diagnostic indicators for acute monocytic leukemia and acute myelomonocytic leukemia (5) . Moreover, the differentiation of myeloid cells could be studied by their ability to synthesize lysozyme in response to various inducers (6) .
We are interested in investigating various aspects of the control ofgene expression and secretion by macrophages and using lysozyme as a tool. Lysozyme is one of the most abundant secretory products of macrophages, representing up to 2.5% of the total protein synthesized in vitro (7) .
Although amino acid sequence data on lysozymes from a large number of species are available, only a few have been cloned (1) . For the phage-type lysozymes, genes of the Escherichia coli phage T4 (8) , Salmonella phage P22 (9) , and Bacillus phage )29 (10) have been isolated. The invertebrate chicken-type lysozyme sequenced and cloned is from the Cecropia moth, Hyalophora cecropia (11) . So far, the best studied vertebrate lysozyme gene is the chicken lysozyme gene (12) . Among mammalian lysozymes, human, baboon, and rat lysozyme have been completely sequenced (1) at the protein level. In this report, we describe the cloning of the human lysozyme cDNA and show that this lysozyme probe can also serve as a very useful tool for studying macrophages in human and other species.* MATERIALS AND METHODS Oligonucleotide Probes. Based on the human lysozyme amino acid sequence (13) , two regions were chosen for oligonucleotide probes on the basis of minimum redundancy in codon usage. The two oligonucleotide probes were synthesized by the solid-phase phosphotriester method (14) . Probes 1 and 2, containing sequences complementary to all the possible combinations of codons for amino acids [27] [28] [29] [30] [31] [32] (Asn-Trp-Met-Cys-Leu-Ala) and 63-68 (Tyr-Trp-Cys-AsnAsp-Gly), respectively, were mixtures of 32 (16) and purification, restriction enzyme digestion, subcloning, and other manipulations of the cloned DNA (17) were as described.
RNA Blot Analysis. Cells were lysed. in guanidinium isothiocyanate (18) and RNA was isolated by ultracentrifugation over a cesium chloride cushion. RNA samples were electrophoresed on a 1% agarose gel with 6% formaldehyde and blotted overnight onto nitrocellulose filter (19) . The filter was hybridized with a cDNA probe prepared from a BamHI/Pst I fragment (see Fig. 2 ) radiolabeled by random priming (20) . The hybridization was carried out in the presence of 50% formamide/10%o dextran sulfate. To detect lysozyme mRNA from other species, the filters were washed under lower stringency conditions (3 x SSC at 60°C for 90 min; 1 x SSC = 0.15 M NaCl/0.015 M sodium citrate).
In Situ Hybridization. The BamHI/Rsa I fragment of the cDNA (see Fig. 2 mRNA and was used as a negative control. Isolated cells were cultured on clean sterile slides overnight, nonadherent cells were washed off, and the slides were'fixed overnight at 40C in 4% paraformaldehyde in phosphate-buffered saline (PBS). The slides were rinsed in PBS, dehydrated in ethanol, and stored dry at -70'C for upto a month. Preparation of tissue sections and in situ hybridization were performed essentially as described (21) .
RESULTS
Cloning of the Human Lysozyme cDNA. Since the complete amino acid sequence of human lysozyme was known, using synthetic oligonucleotides as probes to screen a macrophage cDNA library was the strategy adopted. A clone, designated pHL-1, containing plasmids that hybridized to both probe 1 and 2 was isolated. DNA sequencing performed on both ends of the insert in pHL-1, by the chemical method of Maxam and Gilbert (22) , confirmed that pHL-1 indeed contained the human lysozyme cDNA. The 5' end of this cDNA insert contains a sequence corresponding to the 5' nontranslated region, the signal peptide, and the coding sequence of human lysozyme mRNA. However, the 3' end of pHL-1 was defective. To obtain a proper full-length clone, a BamHI/Pst I restriction fragment of pHL-1 was used as a probe to rescreen the cDNA library. Two more clones, pHL-2 and pHL-3, were isolated and their 5' and 3' terminal sequences were determined. At the' 5' end, pHL-2 contains a 5' nontranslated region 13 nucleotides shorter than that found in pHL-lbut, otherwise, the complete signal peptide and coding sequences. At the 3' end ofpHL-2, a polyadenylylation signal and a poly(A) sequence were found. pHL-3 has the same 3' sequence as pHL-2 but was shorter by =350 bases at the 5' end. Based on this information, pHL-2 was chosen for detailed analysis. The complete DNA sequence of the pHL-2 insert was determined ( Fig. 1) by the Sanger dideoxynucleotide chain-termination method after subcloning into M13 (23) .
A map summarizing the structure of the cDNA is shown in Fig. 2 has all the characteristics of this family of repetitive sequences (Fig. 3) and shows 93% sequence identity with the recently compiled Alu repeat consensus (25) . The A-rich sequences at the end of the first and second monomers are A5TACA6 and A12, respectively. The terminal direct repeats are 13 nucleotides long and, apart from one nucleotide, the two repeats (AAGAACT/GGAATGT) are identical. The Lysozyme mRNA. Based on the RNA blot analysis (Fig. 4) lysozyme mRNA detected was significantly reduced (Fig. 4,  lanes 8 and 9) .
Apart from human lysozyme RNA, both the mouse and rat lysozyme RNA can also be detected in RNA blots by DNA probes prepared from the human lysozyme cDNA under low stringency conditions. The mouse and rat lysozyme RNA is -250 and =350 bases smaller, respectively, than that of the human. So far, using the human lysozyme cDNA probe in RNA blot analyses, detectable hybridization signals have been obtained from human monocytes, U937, HL-60, mouse peritoneal macrophages, mouse spleen macrophages, mouse bone marrow, J774, rat peritoneal macrophages, and the putative rat macrophage line R2 (26), but not from human endothelial cells, HeLa cells, mouse dendritic cells, mouse fibroblasts, mouse keratinocytes, and a number of T-and B-cell lines from human, mouse, and rat.
In Situ Hybridization. Apart from macrophages, it is well known that epithelial cells, such as the Paneth cells, also produce large quantities of lysozyme. Fig. 5 D-F shows hybridization ofthe lysozyme probes to small bowel sections. The results confirm earlier observations using immunocytochemistry that Paneth cells, in intestinal crypts, are major lysozyme producers (27) . As examples of mouse macrophages synthesizing lysozyme, in situ hybridization on cultured mouse thioglycollate-elicited peritoneal macrophages and alveolar macrophages in a lung section are shown (Fig.  5) . As a further specificity control, we have used thioglycollate-elicited peritoneal macrophages cocultured with HeLa cells. Further details of in situ hybridization on other tissues will be presented elsewhere.
DISCUSSION
The use of monoclonal antibodies, such as F4/80 (28) , to localize macrophages in tissues has been very fruitful in studies on the distribution of macrophages under normal and disease states. However, most monoclonal antibodies are species restricted and therefore cannot be used in other animal models. Unlike the approach of using monoclonal antibodies, nucleic acid probes specific for one species can often be used in other species as well. Lysozyme has been shown to be a tissue-restricted marker for myelomonocytic cells, and macrophages cultured in vitro under many different ., arrowhead) . A-C were exposed for 6 days and the rest were exposed for 3 days.
conditions have been shown to produce relatively large quantities of lysozyme (29) . We have therefore chosen to use lysozyme as a tool for in vivo macrophage localization, as well as a model for studying molecular mechanisms involved in the control of gene expression and secretion in macrophages. Through database searches, we have not been able to find reports on cloning of any mammalian lysozyme. Moreover, in our hands, the chicken lysozyme cDNA probe does not cross-hybridize to human or mouse lysozyme mRNAs. Thus, as a first step in our studies, cDNA clones ofthe human lysozyme were isolated and characterized.
The Human Lysozyme cDNA. Sequence analysis on pHL-2, the full-length cDNA clone isolated, shows that apart from the long 3' nontranslated sequence, the human lysozyme cDNA has considerable structural similarity with the chicken cDNA. Fig. 1 shows the comparison of the chicken and human lysozyme cDNA. For the signal peptides, which are both 18 amino acids long, there is 53% similarity both at the level of DNA and amino acid (29% identity and 24% conserved changes). While the mature proteins show a total of 73% similarity (61% identity and 12% conserved changes), there is 61% similarity between the two cDNAs.
The Human Lysozyme mRNA Contains an Inverted Alu Repeat. Most Alu sequences have been found in introns or intergenic regions and only very few have been shown to be present in mature mRNA molecules, although Alu sequencecontaining cytoplasmic RNAs are known to be present (30) . Like all other repetitive sequences, the functional significance of this inverted Alu repeat in the human lysozyme mRNA remains to be determined. Nevertheless, from the evolutionary point of view, it would be interesting to know whether Alu or Alu-like repetitive sequences can be found in the lysozyme mRNA of other primates and mammals, considering the potential effects of these repetitive sequences in reorganizing eukaryotic genomes. The chicken lysozyme gene region has been shown to contain a complex array of at least five classes of repetitive, but probably not Alu-like, sequence (31) , and in the human a-lactalbumin gene (which is structurally and functionally related to lysozyme), an Alu repeat has been found in the first intron (32 In Situ Hybridization. Despite the detailed structural studies on lysozyme, relatively little is known about the biosynthesis and cell source of lysozyme in the animal. We have demonstrated that the lysozyme probe is useful in studying the distribution and identification of tissue macrophages and other lysozyme-secreting epithelial cells, not only in human, but also in other mammals including mouse and rat. It is known that serum lysozyme levels increase in patients with Crohn disease and sarcoidosis, granulomatous diseases in which macrophages are prominent. Therefore, the lysozyme probe could be useful to define the source of lysozyme and the regulation of macrophage activity in these and other inflammatory diseases.
